Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesisVeronica Caraffini, Armin Zebisch, Christine Beham‐Schmid et al.|Haematologica|2019Cited by 18
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltrationVeronica Caraffini, Armin Zebisch, Bianca Perfler et al.|Blood|2018Cited by 16
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivityJohannes Lorenz Berg, Armin Zebisch, Bianca Perfler et al.|Leukemia|2021Cited by 8
<i>RAS</i> -mutant clones drive extramedullary acute myeloid leukemiaPanagiota Chaida, Armin Zebisch, Julia Frimmel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 1
EZH2 inactivation drives MAPK-dependent vulnerability to MEK inhibition in RAS-mutant CMMLEva Gruden, Armin Zebisch, Bianca Perfler et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0